High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65964-ccfa-genetic-microbiome-discoveries-ibd-crohn-s-disease-ulcerative-colitis
SC Johnson, the world’s leading manufacturer of pest control products, is using its 60 years of insect expertise to educate consumers as the Zika virus continues to spread. Immediately following the initial outbreak in Brazil, the company assembled its experts and began developing educational resources for consumers to understand how to best protect themselves against mosquitoes that may carry disease.
In addition to educating consumers, SC Johnson is actively working with organizations around the world to donate and distribute product to those in need. In coordination with the U.S. Centers for Disease Control and Prevention (CDC) Foundation, SC Johnson supported the Zika Action Plan Summit held by the White House and the CDC on April 1, and also donated to the CDC’s Zika Prevention Kits. Additional donations have been made to AmeriCares, the Rio de Janeiro-based Children’s Health Association and the County of Hawaii Civil Defense Agency.
To view the multimedia release go to:
http://www.multivu.com/players/English/7787731-sc-johnson-zika-mosquito-protection/
The Sanford Guide, recognized as the essential reference for infectious disease treatment, announced the release of its first mobile app for the iPhone, iPod touch and iPad. The Sanford Guide App, available on Apple’s App Store for $29.99, contains the comprehensive guidelines and recommendations featured in the well-known pocket-size guides used by health care professionals in treatment decision making for over 40 years.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/sanfordguide/50808/
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area, announced today that the EU Committee for Medicinal Pro-ducts for Human Use (CHMP) recommended that the European Commission approve the use of Xadago™ (safinamide) as add-on to L-dopa alone or in combination with dopamine agonists, entacapone, amantadine, and/or anticholinergics, for the treatment of patients with mid-late stage Parkinson’s disease experiencing motor fluctuations despite being stabilized on ‘Standard of Care’.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406951-chmp-xadago-parkinsons/
Eating difficulties and weight loss can be struggles for people with Alzheimer's and other dementias. The Brookdale Alzheimer's Resource Center offers fresh multimedia information this week to explain the issue and give practical tips to family caregivers on how to make mealtimes easier and more successful for their loved ones.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7087731-brookdale-senior-living/
The website www.MyPerfectDish.eu aims to help people with Parkinson’s, their relatives and caregivers in taking care of their nutritional requirements in order to help them enjoy tasty food that meets their dietary needs.
The website is endorsed by the European Parkinson’s Disease Association (EPDA) and sponsored by Zambon, and has been designed as an easy-to-use scientific information tool so people living with Parkinson’s can be confident that what they are reading is reliable.
“As the only European Parkinson’s umbrella organisation, the EPDA is very proud to endorse this project, which is based on solid scientific and medical grounds,” explains EPDA president Knut-Johan Onarheim. “A balanced and varied diet is important for everyone but it is even more important for people living with Parkinson’s disease because the right food intake can improve their quality of life as well as the effects of therapeutic treatments”.
“Zambon is very proud of having supported this project, which will help people with Parkinson’s and all those involved in the management of the disease. We are strongly committed to drive research and develop solutions to help patients in all their needs“. states Elena Zambon, President of Zambon.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7864251-parkinsons-diet-online-resource/
Under the leadership of the National Organization for Rare Disorders (NORD), the primary organization in the U.S. representing people with rare diseases, millions of Americans will gather tomorrow to observe the 5th annual Rare Disease Day. This international observance unites people around the globe to focus attention on the estimated 300 to 350 million patients worldwide afflicted with rare diseases and to recognize that their needs are a global public health concern. In the U.S., a rare disease is one that affects fewer than 200,000 Americans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60507-nord-rare-disease-day
Over 80% of Americans want to spend their last days at home, with friends and family. Yet, despite these desires, 75% of Americans will spend their last days in a hospital room. Many people will spend hours each day getting painful and often useless treatments and tests, and be asked to take dozens of debilitating drugs. For many, the cure is worse than the disease. This often has negative and lasting effects on family and friends who are often left with feelings of guilt and regret for years to come.
Hospice Support Fund is a 501(c)(3) non-profit organization dedicated to promoting end of life care at home rather than in a hospital so patients can spend their last days in dignity and peace, pain-free in familiar, comfortable surroundings with friends and family.
To view the multimedia release go to:
http://www.multivu.com/players/English/7785451-hospice-support-fund-end-of-life-care-psa/
Upsher-Smith Laboratories, Inc. today announced the nationwide launch of Provella™, a unique probiotic dietary supplement specifically designed for women to promote digestive, feminine, and immune health.* Provella™ helps restore and maintain balance of good bacteria to support digestive and vaginal health.* Taken once-daily by mouth, Provella™ tablets contain a proprietary blend of six bacteria strains that include: Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, and Bifidobacterium bifidum.
Provella™ is available without a prescription behind the pharmacy counter at retail pharmacies nationwide and online at www.drugstore.com. Consumers can also ask any local pharmacist to order Provella™ using List Number 0245-1060-30.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56871-upsher-smith-provella-probiotic-supports-digestive-feminine-immune-health
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
SC Johnson, the world's leading manufacturer of pest control products, is using its 60 years of insect expertise to educate consumers as the Zika virus continues to spread. Immediately following the initial outbreak in Brazil, the company assembled its experts and began developing educational resources for consumers to understand how to best protect themselves against mosquitoes that may carry disease.
For nearly 60 years, SC Johnson entomologists have studied insects at the Entomology Research Center in Racine, Wis., the world's largest private, urban entomology research center. In their research, they help SC Johnson create products that consumers can trust and to provide them with the right product for their pest control needs. SC Johnson is the world's largest manufacturer of insect repellent and household insecticides, including OFF!®, Raid®, Autan® and Baygon®.
To view the multimedia release go to:
http://www.multivu.com/players/English/7787731-sc-johnson-zika-mosquito-protection/#release
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
With September marking National Prostate Cancer Awareness Month and the kick-off of the 2015 NFL season, the Urology Care Foundation and the NFL have renewed their commitment to driving prostate health awareness, as well as teamed up to highlight a Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to take charge of their health through the Know Your Stats® campaign.
The Know Your Stats® campaign is a rallying force to connect, educate and inspire men across the country to know their prostate cancer risk and talk to their doctor about whether prostate cancer testing is right for them.
“It is important for men to know their risk and talk to their doctors so they can determine if prostate cancer testing is right for them,” said Richard A. Memo, MD, Chair of the Urology Care Foundation. “Having the tools and facts empowers individuals and their doctors to make informed decisions.”
Prostate cancer is the second most common cancer in America, affecting one in seven men. Odds increase to one in five if they are African American and one in three if they have a family history; however, the educational tools are making an impact. More men are talking with their doctors and getting tested, and fewer men are dying from the disease.
To view the multimedia release go to:
http://www.multivu.com/players/English/7365551-prostate-cancer-know-your-stats-psa/